News 20.11.2019 URDORF (Zurich), Switzerland, November 18, 2019 / B3C newswire / -- Securecell today announced that it has introduced Sephara, a high performance in-situ filtration membrane for applications in bioprocess sampling and perfusion processes for use in selected bioprocess laboratories. Interested users can participate in an early access program for the...
Internal events
Event date: 03.12.2019
NDA would like to invite you to join us for a morning seminar where our presenters will share their experiences and provide their insights and considerations in order to optimize the value of your development program.
Date: Tuesday 3rd of December 2019
Time: 09:00- 12:15 (opportunity to book 1-1 meetings from 13:15)
Venue:...
Internal events
Event date: 27.11.2019
You are invited to an inspiring panel discussion about entrepreneurship in life science industries hosted by the Swiss INSEAD Healthcare Club (CHIC) on November 27, 2019.
When: Wednesday, November 27, 2019 18:00 sharp (Doors open at 17:30)
Where: Bio-Technopark «Auditorium» at Wagistrasse 25, 8952 Schlieren, Zurich
Program
17:30 Arrival Registration
18:00 Panel Discussion incl. Q&A
19:30...
News 31.10.2019 Zurich-Schlieren, October 31, 2019. Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company that is developing a new class of drugs known as DARPin® therapies*, announced today its Interim Management Statement for the period ending September 30, 2019. “Abicipar represents the first DARPin® therapeutic to be accepted for review by FDA...
Internal events
Event date: 05.11.2019
Prof. Dr. Dr. Vera Regitz-Zagrosek
Charite, Berlin, DE
Sex, gender and drug development
5th of November 2019 at 4 pm
Wagistr. 12 seminar room 4th floor
Drugs may act differently in women and men. Biological differences between women and men may be caused by sex specific gene expression, by sex specific epigenetic modifications and by...